CDK12 is an oncogene, which is up-regulated and has the highest expression level in Acute Myeloid Leukemia (AML) (Figure 6(D)), while its boundary partner non-oncogene PSMD3 shows down-regulation in AML patients (Figure 6(E)). This evidence concerns the gene CDK12 and acute myeloid leukemia.